Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer Meeting Abstract


Authors: Flaherty, K.; Puzanov, I.; Sosman, J.; Kim, K.; Ribas, A.; McArthur, G.; Lee, R. J.; Grippo, J. F.; Nolop, K.; Chapman, P.
Abstract Title: Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 461s
Language: English
ACCESSION: WOS:000276606606016
PROVIDER: wos
DOI: 10.1200/jco.2009.27.15_suppl.9000
Notes: Meeting Abstract: 9000 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman